A Preview Of Acurx Pharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
Acurx Pharmaceuticals (NASDAQ:ACXP) is scheduled to release its quarterly earnings report on March 18, 2024, with analysts expecting an EPS of $-0.26. The company's past earnings performance shows a pattern of beating EPS estimates, which has occasionally led to positive stock price movements the following day. However, the stock has experienced a 7.19% decline over the last 52 weeks, indicating a bearish sentiment among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.
March 15, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Acurx Pharmaceuticals is expected to announce its quarterly earnings with an anticipated EPS of $-0.26. Historical data shows its ability to beat EPS estimates, potentially influencing stock price positively if the trend continues. However, the stock's 7.19% decline over the past year suggests a bearish outlook among investors.
The anticipation of Acurx Pharmaceuticals' earnings report and its history of beating EPS estimates could lead to short-term positive sentiment among investors. However, the overall bearish trend over the past year tempers expectations for a significant positive impact. The company's guidance will be crucial in determining the stock's direction.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100